The news led to a stock surge on expectations that forthcoming data for the company’s experimental gene therapy for Rett ...
READ ALSO: 10 Most Promising Biotech Stocks According to Hedge Funds. The cell and gene therapy sector has faced significant investment challenges since the boom years of 2020 and 2021.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback